Navigation Links
VARICELLA-ZOSTER (VZ) IgG IFA TEST SYSTEM

ProductsVARICELLA-ZOSTER (VZ) IgG IFA TEST SYSTEM
Company Zeus Scientific, Inc.
Item VARICELLA-ZOSTER (VZ) IgG IFA TEST SYSTEM
Features 
  • Rapid & Specific
  • Qualitative & Semi-Quantitative Procedures
  • Choice of slide configurations (6, 8, 12, 16, 24, 96 wells)
  • Consistent product quality & availability
  • Conjugates & substrates optimized to reduce background staining - Easy to read
  • Stable substrates providing extended expiration dates
  • ZORBA IgG Removal Reagent® for use in performing IgM detection assays - reduces false negative & false positive reactions due to IgG and RF interference
  • Multiple tissue slides for simultaneous detection of multiple antibodies
Description Varicella-Zoster (VZ) test system is intended for the qualitative and semi-quantitative detection of VZ IgG antibody in human sera by the indirect fluorescent antibody (IFA) technique. The assay can determine or confirm a recent infection or immune status, and is for in vitro diagnostic use.
Info Zeus Scientific, Inc.
Customer Service: (800) 286-2111
Web site: http://www.zeussci.com

Related medicine products :

1. DUALSWITCH-SHUNTSYSTEM for L-P-Derivation
2. ISYSTEM-ABDv2™A/B Scan unit
3. ISYSTEM-ABD A/B-scan unit
4. SEDIPLAST ESR SYSTEM (without diluent)
5. SEDIPLAST ESR SYSTEM (with diluent)
6. ISYSTEM-ABDv2A/B Scan unit
7. The REFLEXION 1st MPJ IMPLANT SYSTEM
8. MEASLES (Rubeola) IgG ELISA TEST SYSTEM
9. MUMPS IgG ELISA TEST SYSTEM
10. SYSTEM ONE Orbital Illumination System
11. ALEXI® WOUND RETRACTOR SYSTEM
ELISA for detection of Anti-Gliadin IgA....
An enzyme-linked immuno-sorbent assay for the detection and quantitation of anti-tissue Transglutaminase in serum of patients with Celiac Disease and Dermatitis Herpetiformis....
Enzyme immunoassay for the quantitative determination of Gliadin-IgA antibodies in serum and plasma. This kit provides specific determination of gliadin antibodies by using highly purified gliadin....
... immunosorbent assay method for the semi-quantitative determination ... human serum. The results of the anti-Gliadin ... aid in the diagnosis of diseases associated ... Coeliac Disease. Levels of these autoantibodies are ...
Medicine Products:
(Date:4/25/2017)... ... April 25, 2017 , ... Back Pain Centers ... back pain with a reputable physician in their area, announces the launch of a ... information for patients who are looking for reputable physicians to help them with back ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... addition of predictive analytics to its patient care management module. Using this new ... before a patient has been initiated on continuous positive airway pressure (CPAP), oral, ...
(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol USA® ... introducing Flexadin UCII, part of the EQUISTRO line, at this week’s Rolex Kentucky ... horses at the immunologic level. , The scientifically-developed Flexadin UCII supports the body’s ...
(Date:4/24/2017)... ... April 24, 2017 , ... LG ... Your Own Device (BYOD) capabilities at Telehealth 2.0, the American Telemedicine Association’s national ... which pairs medical devices with a pre-programmed tablet in a remarkably easy-to-use kit ...
(Date:4/24/2017)... ... 2017 , ... Ridgecrest Herbals makes it a point to lead the Utah ... and support renewable energy. They believe this is a crucial part of their mission ... health issues, and maintain that destroying the environment in the pursuit of profit is ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, today ... C virus (HCV) infected patients with genotype 1, ... (Child-Pugh A) achieved sustained virologic response at 12 ... pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high SVR ... of G/P treatment without ribavirin. Patients with specific ...
(Date:4/20/2017)... Sweden , April 20, 2017 ... NEVPF) ("NeuroVive") today announced positive preclinical results ... preclinical compound for non-alcoholic steatohepatitis (NASH), in ... NV556 has previously shown ... NASH model. Today, NeuroVive,s scientists present novel ...
(Date:4/19/2017)... NEW YORK , April 19, 2017 Cardiology ... during the projected period The Cardiology Devices segment ... more than US$ 15 Mn in 2018 over 2017. By ... reach a market valuation close to US$ 700 Mn, expanding ... Cardiology Devices segment dominated the Asia Pacific ...
Breaking Medicine Technology: